Hernan Cuevas Brun, Business Development Manager and Aerosol Drug Delivery Scientist at HCmed Innovations, this week shares his experience working in the industry of developing nebulizers and combination products.

This week Yuan-Ming Hsu, Director of the R&D Department at HCmed Innovations, shares his thoughts and experience working in the medical device industry.

HCmed's COO, Leon Tsai, shares his experience in the development of mesh nebulizer and his motivation to improve these devices to provide more effective solutions for inhalation therapy.

HCmed Innovations Co., Ltd. (HCmed) and Cellics Therapeutics, Inc. (Cellics) have initiated a collaboration, introducing inhalation therapy for the delivery of nanospages.

HCmed Innovations Co., Ltd. (HCmed) is honored to be listed as one the winners awarded for its growth potential.

HCmed Innovations is delighted to announce that it has received US Food and Drug Administration (FDA) 510(k) clearance for its portable mesh nebulizer, Pulmogine.

HCmed Innovations (HCmed) signed an agreement with Cathay Securities on June 21st, 2021, to prepare for its initial public offering (IPO).

Companies Initiated Phase I trial in December 2020

In its second consecutive year showcasing as an invited guest of I-Campus at the CIIE, HCmed Innovations was delighted to introduce its new smart device prototype